Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(86)
Filter by content year
2024
(2)
2023
(18)
2022
(26)
2021
(16)
2020
(22)
2019
(2)
Filter by form group
Filter by category
(-)
All
(86)
(-)
Events
(86)
Financial
(42)
Other
(37)
Collaborators
(13)
Science
(7)
Clinical
(5)
Filter by category
Search
News
BioNTech veröffentlicht Ergebnisse des dritten Quartals und Informationen zur Geschäftsentwicklung
News
BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress
News
Pfizer und BioNTech schließen Liefervereinbarung mit der EU über 200 Millionen Dosen ihres mRNA-basierten Impfstoffkandidaten BNT162b2 gegen COVID-19
News
Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19
News
BioNTech gibt Pressekonferenz für ein Update über das COVID-19-Impfstoffentwicklungsprogramm
News
BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
News
BioNTech gibt Pressekonferenz zum Fortschritt im COVID-19-Impfstoffentwicklungsprogramm
News
BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
News
BioNTech veröffentlicht am 8. August 2022 Ergebnisse des zweiten Quartals sowie Informationen zum operativen Fortschritt
News
BioNTech to Report Second Quarter 2022 Financial Results and Operational Update on August 8, 2022
Pagination
Page 1
Next page
››